← Back to Search

Behavioural Intervention

Collaborative Care Model for Type 1 Diabetes

N/A
Recruiting
Led By Leslie Johnson, PhD, MPH
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (≥18 years) with T1D (based on clinical record diagnosis)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 months
Awards & highlights

Summary

This trial aims to see if a new approach to care can help improve the health of adults with type 1 diabetes. The study will last for 18 months and involve participants completing online surveys every six

Who is the study for?
Adults over 18 with type 1 diabetes can join this trial. It's not for those who have severe psychiatric illness, active suicidal thoughts, or don't speak English/have phone access.Check my eligibility
What is being tested?
The study is comparing usual care for type 1 diabetes against a collaborative care model (CoCM) that includes regular online surveys and consultations with a behavioral health consultant.See study design
What are the potential side effects?
Since the interventions involve healthcare management rather than medication, there are no direct side effects; however, participants may experience stress or discomfort from additional surveys and consultations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an adult diagnosed with Type 1 Diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients achieving improvement in HbA1c at end of intervention
Proportion of patients achieving improvements in PHQ-9 score
Secondary outcome measures
Generalized anxiety disorder scale score
Low-density lipoprotein (LDL) cholesterol
Systolic and diastolic blood pressure (BP) measurements

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Collaborative care groupExperimental Treatment2 Interventions
Enrolled participants assigned to the intervention arm will be offered free consultation services with a behavioral health specialist, who is also a licensed clinical social worker. Participants randomized into the intervention group will consult with a behavioral health consultant (BHC) one or more times over the intervention period (based on the assessment of the BHC) via phone or Zoom based on the participant's preference. The BHC will participate in systematic caseload reviews to facilitate the medical management of depression if indicated.
Group II: Usual CareActive Control1 Intervention
Participants randomized to the usual care will continue their routine clinical care at the diabetes clinic at Grady.

Find a Location

Who is running the clinical trial?

MQ Mental Health ResearchUNKNOWN
Juvenile Diabetes Research FoundationOTHER
234 Previous Clinical Trials
142,101 Total Patients Enrolled
Emory UniversityLead Sponsor
1,655 Previous Clinical Trials
2,572,403 Total Patients Enrolled
~53 spots leftby Jan 2026